Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImmunoGen's antibody humanization technology reported to be superior to conventional methods

Oct. 25, 1996

Megabios in vivo gene delivery systems available for licensing

Oct. 25, 1996

Pharmacopeia receives patent coverage for drug discovery technology

Oct. 25, 1996

P&U reports compounds for improving drug bioavailability

Oct. 25, 1996

Funding for Genetronics' electroporation delivery technology

Oct. 18, 1996

Regeneron-Pharmacopeia drug discovery collaboration

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Palatin receives grants for the development of peptide-based therapeutics and diagnostics

Oct. 11, 1996

Geron licenses technologies for use in the treatment of age-related diseases

Oct. 11, 1996

Patent coverage for new gene expression system

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...